CGA
BSX icon

Compound Global Advisors’s Boston Scientific BSX Stock Holding History

Compound Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.1K Buy
+750
New +$60K 1.46% 22
2024
Q1 		$5.27M Sell
76,882
-46,733
-38% -$3M 0.78% 36
2023
Q4 		$7.15M Buy
123,615
+27,860
+29% +$1.49M 1.32% 30
2023
Q3 		$5.06M Buy
+95,755
New +$5.02M 1.11% 30

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Compound Global Advisors's BSX Position: Q1 2026 in Review

Compound Global Advisors opened a new position in Boston Scientific (BSX) in Q1 2026: 750 shares worth $47.1K. The stake represents 1.46% of the portfolio and ranks #22 among its holdings. This is a return to the name: Compound Global Advisors previously reported a position in BSX as recently as Q1 2024.

Compound Global Advisors first reported a position in BSX in Q3 2023 and has held it in 4 quarters since. The position peaked at $7.15M in Q4 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Compound Global Advisors held 750 shares of Boston Scientific worth $47.1K as of Q1 2026.
  • Boston Scientific was a new Compound Global Advisors position in Q1 2026.
  • Boston Scientific made up 1.46% of Compound Global Advisors's portfolio in Q1 2026, its #22 holding.
  • Compound Global Advisors first reported a position in Boston Scientific in Q3 2023 and has held it in 4 quarters since.
  • Compound Global Advisors's Boston Scientific position peaked at $7.15M in Q4 2023.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Compound Global Advisors's 13F filing for Q1 2026, filed 7 May 2026.